Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Item TypeItem Type
-
SubjectSubject
-
YearFrom:-To:
-
More FiltersMore FiltersSourceLanguage
Done
Filters
Reset
41
result(s) for
"Grotenhuis, Andre"
Sort by:
Endocrinological aspects of pituitary adenoma surgery in Europe
by
Thomas, Nick
,
Kosák, Mikuláš
,
Ringel, Florian
in
631/378/1689
,
692/163/2743/2742/1738
,
Adenoma
2022
Hormone-secreting adenomas are treated in many neurosurgical centers within Europe. The goal of the survey is to understand variance in practice management of pituitary tumors amongst neurosurgical centers. A list of departments performing pituitary surgery was created. The survey consisted of 58 questions. This study focuses on neurosurgical care of hormone-secreting adenomas. For analysis, the departments were divided into four subgroups: academic/non-academic, high-volume/low-volume, “mainly endoscopic/mainly microscopic practice” and geographical regions. Data from 254 departments from 34 countries were obtained. Most centers surgically treat 1–5 hormone-secreting adenomas per year. In prolactinomas this is the case in 194 centers, (76.4%), in GH-secreting adenomas: 133 centers, (52.4%), ACTH-secreting adenomas: 172 centers, (69.8%). Surgery as a primary treatment of prolactinomas is considered in 64 centers (25.2%). In 47 centers (18.8%), GH-secreting microadenomas are often treated pharmacologically first. Debulking surgery for an invasive GH-secreting adenoma in which hormonal remission is not a realistic goal of the surgery and the patient has no visual deficit surgery is always or mostly indicated in 156 centers (62.9%). Routine postoperative hydrocortisone replacement therapy is administered in 147 centers (58.6%). Our survey shows that in most centers, few hormone-secreting adenomas are treated per year. In about 25% of the centers, prolactinoma surgery may be regarded as first-line treatment; in about 20% of the centers, medical treatment is the first-line treatment for GH-secreting adenomas. Pretreatment for ACTH-secreting adenomas is routinely used in 21% of centers. This survey may serve as plea for neurosurgical care centralization of hormone-secreting adenomas.
Journal Article
How to define CSF overdrainage: a systematic literature review
by
Hamilton, Mark G
,
Rekate, Harold
,
Thomale, Ulrich-Wilhelm
in
Cerebrospinal fluid
,
Drainage
,
Hydrocephalus
2023
Abstract Purpose Overdrainage (OD) is one of the most frequent complications related to drainage of the cerebrospinal fluid (CSF). It is mostly associated with valve-bearing shunt systems but should probably be considered as a risk factor in any type of CSF diversion procedure. There is extreme variation in the reported incidence of OD due to the lack of consensus on defining criteria and an unclear perception of the pathophysiology. Hence, OD is probably underreported and underestimated. The objective of this paper was to establish a definition of OD, based on a systematic review of the literature.MethodsA systematic search was conducted in MEDLNE and EMBASE. Studies providing a definition or a description of diagnostic findings related to OD in ventriculoperitoneal shunt treated hydrocephalus were included. Non-English titles, abstracts and manuscripts were excluded. Extracted descriptions were graded into five groups (class I-V studies) based on how precise the terminology used to describe OD was. Class I studies were included for further analysis and characteristics of OD were extracted. The quality of included descriptions was assessed by a clinical expert panel.ResultsA total of 1309 studies were screened, 190 were graded into groups, and 22, which provided specific definitions or descriptions of OD, were graded as class I studies. We extracted 32 different characteristics consistent with OD (e.g., clinical symptoms, radiological signs, and syndromes).ConclusionThere was an overall agreement that CSF overdrainage following implantation of a ventriculoperitoneal shunt in a mixed pediatric and adult population is characterized as a persistent condition with clinically manifestations as postural dependent headache, nausea, and vomiting and/or radiological signs of slim ventricles and/or subdural collections.
Journal Article
Collision sellar lesions: experience with eight cases and review of the literature
by
Wesseling, Pieter
,
Seretis, Andreas
,
Koutourousiou, Maria
in
ACTH-Secreting Pituitary Adenoma - pathology
,
Adult
,
Aged
2010
The concomitant presence of a pituitary adenoma with a second sellar lesion in patients operated upon for pituitary adenoma is an uncommon entity. Although rare, quite a great variety of lesions have been indentified coexisting with pituitary adenomas. In fact, most combinations have been described before, but an overview with information on the frequency of combined pathologies in a large series has not been published. We present a series of eight collision sellar lesions indentified among 548 transsphenoidally resected pituitary adenomas in two Neurosurgical Departments. The histological studies confirmed a case of sarcoidosis within a non-functioning pituitary adenoma, a case of intrasellar schwannoma coexisting with growth hormone (GH) secreting adenoma, two Rathke's cleft cysts combined with pituitary adenomas, three gangliocytomas associated with GH-secreting adenomas, and a case of a double pituitary adenoma. The pertinent literature is discussed with emphasis on pathogenetic theories of dual sellar lesions. Although there is no direct evidence to confirm the pathogenetic relationship of collision sellar lesions, the number of cases presented in literature makes the theory of an incidental occurrence rather doubtful. Suggested hypotheses about a common embryonic origin or a potential interaction between pituitary adenomas and the immune system are presented.
Journal Article
The ASPECT Hydrocephalus System: a non-hierarchical descriptive system for clinical use
by
oughi, Mansoor
,
Rekate, Harold
,
Pedersen, Sarah Skovlunde Hornshøj
in
Cerebrospinal fluid
,
Classification
,
Classification systems
2023
In patients with hydrocephalus, prognosis and intervention are based on multiple factors. This includes, but is not limited to, time of onset, patient age, treatment history, and obstruction of cerebrospinal fluid flow. Consequently, several distinct hydrocephalus classification systems exist. The International Classification of Diseases (ICD) is universally applied, but in ICD-10 and the upcoming ICD-11, hydrocephalus diagnoses incorporate only a few factors, and the hydrocephalus diagnoses of the ICD systems are based on different clinical measures. As a consequence, multiple diagnoses can be applied to individual cases. Therefore, similar patients may be described with different diagnoses, while clinically different patients may be diagnosed identically. This causes unnecessary dispersion in hydrocephalus diagnostics, rendering the ICD classification of little use for research and clinical decision-making. This paper critically reviews the ICD systems for scientific and functional limitations in the classification of hydrocephalus and presents a new descriptive system. We propose describing hydrocephalus by a system consisting of six clinical key factors of hydrocephalus: A (anatomy); S (symptomatology); P (previous interventions); E (etiology); C (complications); T (time–onset and current age). The “ASPECT Hydrocephalus System” is a systematic, nuanced, and applicable description of patients with hydrocephalus, with a potential to resolve the major issues of previous classifications, thus providing new opportunities for standardized treatment and research.
Journal Article
Avoiding predatory publishing for early career neurosurgeons: what should you know before you submit?
2021
BackgroundScientific research can offer the joy of discovery. For many graduating neurosurgeons, often, a seminar, class, or instructional module is their first and only formal exposure to the world of conducting research responsibly, to write down and report the results of such research. The pressure to publish scientific research is high, but any young neurosurgeon who is unaware of how predatory publishers operate can get duped by it and can lose their valuable and hard-fought research. Hence, we have attempted to provide an overview of all potentially predatory neurosurgery publications and provide some “red flags” to recognize them.MethodsA suspected list of predatory publications was collected via a thorough review of the Neurosurgery journals listed in 4 major so-called blacklists, i.e., Beall’s list, Manca’s list, Cabell’s blacklist, and Strinzel blacklist and then cross-referenced with UGC CARE whitelist to remove any potential legitimate journals. All journals with a scope of the Neurosurgery publication were searched using terms in the search bar: “Neurosurgery”, “Neuroanatomy”, “Neuropathology”, and “Neurological disorder/disease”. Since all predatory journals claim to be open access, all possible types of open access journals on Scimago were also searched, and thus a comparison was possible in terms of publication cost and number of legitimate open access journals when compared with predatory ones. In addition, methodologies by which these journals penetrate legitimate indexes like PubMed was investigated.ResultsA total of 46 predatory journals were found and were enlisted along with their publishers and web addresses. Sixty of the 360 Neurosurgery journals listed on Scimago were open access and the fee for the predatory journals was substantially lower (< $150) when compared with legitimate journals ($900–$3000). Six types of open access types exist while a total of 26 red flags in 7 stages of publication can be found in predatory journals. These journals have penetrated indexes by having similar names to legitimate journals and by publishing articles with external funding which mandate their indexing.ConclusionThese 46 journals were defined as predatory by 4 major blacklists, and none of them was found in the UGC Care white list. They also fulfill the 26 red-flags that define a predatory journal. The blacklist detailed here may become redundant; hence “whenever in doubt” regarding a journal with “red-flags”, the authors are advised to refer to whitelists to be on the safer side. Publishing in predatory journals leads to not only loss of valuable research but also discredits a researcher among his peers and can be hindrance in career progression. Some journals are even indexed on PubMed, and they have sophisticated webpages and high-quality online presentations.
Journal Article
Armored brain in a young girl with a syndromal hydrocephalus
by
van Baarsen, Kirsten
,
Viozzi, Ilaria
,
Grotenhuis, André
in
Adolescent
,
Calcinosis - etiology
,
Calcinosis - therapy
2017
The authors present a case of a young girl affected by a syndromal hydrocephalus who developed a bilateral ossified chronic subdural hematoma with the typical radiological appearance of \"the armored brain\". Bilateral calcified chronic subdural hematoma is a rare complication of ventriculoperitoneal shunt. There is controversy in the treatment, but most published literature discourages a surgical intervention to remove the calcifications.
Journal Article
Genetic analysis of spinal dysraphism with a hamartomatous growth (appendix) of the spinal cord: a case series
by
Grotenhuis, J. Andre
,
Brunner, Han
,
Bartels, Ronald H. M. A.
in
Abnormal development
,
Adult
,
Appendix
2020
Background
Spinal dysraphism with a hamartomatous growth (appendix) of the spinal cord is better known as herniated spinal cord. There are many arguments in favour of considering it a developmental defect. From this point of view, it is a type of neural tube disorder. Neural tube disorders can be caused by multiple factors, including a genetic factor. A common genetic defect in patients with a spinal dysraphism with a hamartomatous growth of the spinal cord is sought for.
Case presentation
In two patients with a symptomatic lesion and referred to an academic hospital a genetic analysis was performed after informed consent. Whole-exome analysis was performed.
:
Whole-exome analysis did not result in identification of a clinically relevant genetic variant.
Conclusions
This the first study to investigate the genetic contribution to spinal dysraphism with a hamartomatous growth (appendix) of the spinal cord. We could not establish a genetic cause for this entity. This conclusion cannot be definitive due to the small sample size. However, the incidental occurrence, the lack of reports of inheritance of this disorder and the absence of contribution to syndromal disorders favours a defect of normal development of the spinal cord.
Journal Article
Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas
2022
Objective. Pituitary adenoma surgery has evolved rapidly in recent decades. This study aims to determine current practice across a wide range of European neurosurgical centers. Methods. A list of eligible departments performing pituitary adenoma surgery was created. The survey consisted of 58 questions. For analysis, the departments were divided into four subgroups: academic/nonacademic, high-volume/low-volume, “mainly endoscopic/mainly microscopic practice,” and geographical regions. Results. Data from 254 departments from 34 countries were obtained. In 108 centers (42.5%), <30 pituitary adenomas were operated per year. Twenty (7.9%) centers performed >100 adenoma surgeries per year. Number of neurosurgeons performing endonasal surgeries are as follows: 1 in 24.9% of centers and 2 in 49.8% of centers. All residents assisted endonasal surgeries in 126 centers (49.8%). In 28 centers (21.1%), all residents performed endonasal surgery under supervision during residency. In 141 centers (56.8%), the endoscopic approach was used in >90% of the surgeries. Regular pituitary board (either weekly or once a month) meetings were held in 147 centers (56.3%). Nonfunctioning adenomas represent >70% of pituitary caseload in 149 centers (58.7%). Conclusions. In our survey, most centers perform less than 100 surgeries for pituitary adenomas. In most centers, pituitary surgeries are performed by one or two neurosurgeons. Residents have a limited exposure to this type of surgery, and the formal pituitary board is not a standard. Nonfunctioning adenomas make up most of surgically treated adenomas. This study can serve as a benchmark for further analyses of pituitary adenoma centers in Europe.
Journal Article
Long-term Results of the Neuroendoscopic Management of Colloid Cysts of the Third Ventricle: A Series of 90 Cases
2011
Abstract
BACKGROUND:
The endoscopic removal of third ventricular colloid cysts has been developed as an alternative to microsurgical transcortical-transventricular and transcallosal approaches.
OBJECTIVE:
To examine the value of endoscopic technique by reviewing the large number of endoscopically treated patients with long-term follow-up in 2 neurosurgical centers.
METHODS:
A retrospective chart review was conducted for all patients admitted for resection of a third ventricular colloid cyst to the Radboud University Nijmegen Medical Centre (Nijmegen, the Netherlands) and the Hôpital Henri Mondor (Paris, France) between 1994 and 2007. Both clinical and radiological symptoms and operative results were evaluated.
RESULTS:
Postdischarge clinical follow-up was available for 85 patients over a mean period of 4 years 3 months. Permanent morbidity occurred in 1 patient (persisting preoperative memory deficit). Follow-up imaging of 80 evaluable patients showed that total or nearly total cyst removal was possible in 46 individuals (57.5%). Residual cyst was present in 34 patients (42.5%), and 6 required repeated endoscopic surgery for symptomatic regrowth. Recurrent cysts were mainly seen within the first 2 years after surgery.
CONCLUSION:
It is debatable whether the higher numbers of recurrent or residual cysts can be justified by the slightly lower complication rates achieved with endoscopic removal. However, results have been improving over the years. Moreover, the modifications observed on control magnetic resonance images justify the need for regular control imaging for at least the first 2 years postoperatively.
Journal Article